Literature DB >> 11198660

Miltefosine in a case of visceral leishmaniasis with HIV co-infection; and rising incidence of this disease in India.

C P Thakur1, P K Sinha, R K Singh, S M Hassan, S Narain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11198660     DOI： 10.1016/s0035-9203(00)90238-4

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  8 in total

1.  Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region.

Authors:  F Pasquau; J Ena; R Sanchez; J M Cuadrado; C Amador; J Flores; C Benito; C Redondo; J Lacruz; V Abril; J Onofre
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-06       Impact factor: 3.267

2.  Alkyl-lysophospholipid resistance in multidrug-resistant Leishmania tropica and chemosensitization by a novel P-glycoprotein-like transporter modulator.

Authors:  J M Pérez-Victoria; F J Pérez-Victoria; A Parodi-Talice; I A Jiménez; A G Ravelo; S Castanys; F Gamarro
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

3.  Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis.

Authors:  Brajendra Tiwari; Richa Pahuja; Pradeep Kumar; Srikanta Kumar Rath; Kailash Chand Gupta; Neena Goyal
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

4.  Pharmacotherapeutic options for visceral leishmaniasis-current scenario.

Authors:  Krishna Pandey; Prabhat Kumar Sinha; Vidyanand Ravi Das; Sanjiva Bimal; Shubhankar K Singh; Pradeep Das
Journal:  Clin Med Pathol       Date:  2009-01-23

Review 5.  The relationship between leishmaniasis and AIDS: the second 10 years.

Authors:  Jorge Alvar; Pilar Aparicio; Abraham Aseffa; Margriet Den Boer; Carmen Cañavate; Jean-Pierre Dedet; Luigi Gradoni; Rachel Ter Horst; Rogelio López-Vélez; Javier Moreno
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

6.  Visceral leishmaniasis with HIV co-infection and cervical lymphadenopathy.

Authors:  Sanjay Mishra; Ayush Shukla; Anil Kumar Tripathi; Ashutosh Kumar
Journal:  BMJ Case Rep       Date:  2013-04-09

7.  Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome).

Authors:  Sakib Burza; Raman Mahajan; Prabhat K Sinha; Johan van Griensven; Krishna Pandey; María Angeles Lima; Marta Gonzalez Sanz; Temmy Sunyoto; Sunil Kumar; Gaurab Mitra; Ranjeet Kumar; Neena Verma; Pradeep Das
Journal:  PLoS Negl Trop Dis       Date:  2014-08-07

8.  Quality of life perceptions amongst patients co-infected with Visceral Leishmaniasis and HIV: A qualitative study from Bihar, India.

Authors:  Mohit Nair; Pragya Kumar; Sanjay Pandey; Shahwar Kazmi; Laura Moreto-Planas; Alok Ranjan; Sakib Burza
Journal:  PLoS One       Date:  2020-02-10       Impact factor: 3.240
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.